Guanhao Biotech Co (SZSE:300238) Net Issuance of Preferred Stock : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Guanhao Biotech Co's net issuance of preferred for the three months ended in Mar. 2024 was ¥0.0 Mil. The number is 0, which means that Guanhao Biotech Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Guanhao Biotech Co's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.

Guanhao Biotech Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Guanhao Biotech Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Net Issuance of Preferred Stock Chart

Guanhao Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Guanhao Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Guanhao Biotech Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Guanhao Biotech Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Guanhao Biotech Co (SZSE:300238) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530

Website

http://www.grandhopebio.com

Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.

Executives

Liu De Wang	Directors, executives
Zhao Jun Hui	Directors, executives
Yang Guo Sheng	Supervisors
Zhu Wei Ping	Director
Hu Jun	Securities Affairs Representative
Jia Bao Rong	Executives
Jia Jun Chao	Executives
Di Pu	Director
Zhuo Fu Min	Director
Guo Xiao Ming	Executives
Zhang Hong Tao	Executives
Zhao Wen Jie	Executives
Guan Xin	Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines